This website uses functional cookies, including analytical cookies.
The obtained statistical data cannot be traced back to individual users.
Additionally, you can choose to accept or refuse consent to use marketing cookies.
If you decline these additional cookies or refrain from making a choice, only functional cookies will be set.
See our cookie policy for more information.
Assessment Of Supply Chain Risk Key To Improving Medicine Access
Assessment Of Supply Chain Risk Key To Improving Medicine Access
A four-year research project to study drug shortages in six European countries by INSEAD and five other institutions including RSM sheds light on how understanding medical criticality, supply chain risk and their interactions could help us better address drug shortages. Co-written by Stef Lemmens and Harwin de Vries.